Usefulness of miglitol in patients with diabetes mellitus type 2 and insufficient control of the blood glucose;Utilidad del miglitol en pacientes con diabetes mellitus tipo 2 y mal control glucémico

Revista Clinica Espanola

Volumn 204, Issue 1, 2004, Pages 32-34

  de Luis Roman D A ^a,b   del Pozo Garcia E ^a   Aller, R ^a   Romero Bobillo, E ^a   Conde Valentin R ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b NONE   (Spain)

Author keywords

Diabetes type 2; Miglitol

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA GLUCOSIDASE INHIBITOR; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MIGLITOL; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; SYSTOLIC BLOOD PRESSURE;

EID: 1442325582     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13056791     Document Type: Article

References (8)

1. Stout RW. Insulin and atheroma. Diabetes Care 1990;13:631-54.
2. Segal P, Feig PU, Schernthaner G, Ratzmann KP, Rybka J, Petzinna J, et al. The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequeately controlled by diet alone. Diabetes Care 1997;20:687-91.
3. Dimitriadis G, Hatziagellaki E, Alexopoulos E. Effects of alfa-glicosidase inhibition on meal glucose tolerance and timing of insulin administration in patients with type 1 diabetes mellitus. Diabetes Care 1991;15:393-8.
4. Mitrakou A, Tountas N, Raptis AE, Bauer RJ, Schulz H, Raptis SA. Long term effectiveness of a new alfa-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus. Diabetic Med 1998; 15:657-60.
5. Johnson AB, Taylor R. Does suppression of postprandial blood glucose excursions by alfa-glicosidase inhibitor miglitol improve insulin sensitivity in diet treated type II diabetic patients? Diabetes Care 1996;19:559-63.
6. Pagano G, Marena S, Corgiat-Mansin L, Cravero F, Giorda C, Bozza M, et al. Comparison of miglitol and glibenclamide indiet-treated type 2 diabetic patients. Diabetes Metabol 1995;21:162-7.
7. Johnston PS, Coniff RF, Hoogwerf BJ, Santiago JV, Pi-Sunyer FX, Krol A. Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients. Diabetes Care 1994;17:20-9.
8. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibault N, et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance of diabetes: results from the 11 year follow-up of the Paris Prospective Study. Diabetologia 1989;32:300-4.